Suspension
| GENERIC NAME | COMPOSITION | SPEC. | QTY | UNIT |
|---|---|---|---|---|
| Sucralfate Suspension | Each 10 ml contains Sucralfate Excipients Excipients | IP | 1 Q.S. | GM |
| Albendazole & Ivermectin Suspension | Each 5 ml contains Albendazole Ivermectin In a flavoured syrupy base Approved colour used | IP IP | 200 1.5 | mg |
| Aluminium Hydroxide, Magnesium Hydroxide & Simethicone Suspension | Each 5 ml contains Dried Aluminium hydroxide Gel Magnesium Hydroxide Simethicone Excipients Approved Colour used | IP IP IP | 250 250 50 Q.S. | mg mg mg |
| Clarithromycin Suspension | Each 5 ml contains Clarithromycin Excipients Colour: approved colour used | USP | 125 Q.S. | mg |
| Clarithromycin Suspension | Each 5 ml contains Clarithromycin Excipients Colour: approved colour used | USP | 250 Q.S. | mg |
| Fexofenadine hydrochloride Suspension | Each 5 ml contains Fexofenadine Hydrochloride Approved Colour used | IP | 30 | mg |
| Levofloxacin & Ornidazole suspension | Each 5 ml contains Levofloxacin Hemihydrate eq. to Levofloxacin Ornidazole Excipients Approved Colour used | IP IP | 125 125 Q.S. | mg mg |
| Mefenamic Acid 100 mg & Paracetamol 250 mg Suspension | Each 5 ml contains Mefenamic Acid Paracetamol Excipients Approved Colour Used | IP IP | 100 250 Q.S. | mg mg |
| Aceclofenac & Paracetamol Suspension | Each 5 ml contains Aceclofenac Paracetamol Flavoured syrupy base Approved Colour Used | IP IP | 50 125 | mg mg |
| Ofloxacin & Metronidazole Suspension | Each 5 ml contains Ofloxacin Metronidazole Benzoate Eq. to Metronidazole Flavoured syrupy base Approved Colour Used | IP IP | 100 200 | mg mg |
| Levofloxacin Suspension | Each 5 ml contains Levofloxacin Hemihydrate eq. to Levofloxacin Excipients Approved Colour used | IP | 125 Q.S. | mg |
| Paracetamol & Ibuprofen suspension | Each 5 ml contains Ibuprofen Paracetamol flavoured syrupy base Approved Colour used | IP IP | 100 162.5 Q.S. | mg mg |
| Fexofenadine Hydrochloride & Montelucast Sodium oral suspension | Each 5ml contains Fexofenadine Hydrochloride Montelucast sodium Eq. to Montelucast In a flavoured syrupy base Approved colour used | IP IP | 60 4 Q.S. | mg mg |
| Rifaximin Oral Suspension | Each 5 ml Suspension contains Rifaximin In a flavoured syrupy base Approved colour used | BP | 100 | mg |
| Sucralfate, Oxetacaine Suspension | Each 10 ml contains Sucralfate Oxetacaine Excipients Approved colour used | IP BP | 1 20 Q.S. | gm mg |
| Albendazole Suspension | Each 5 ml contains Albendazole With Flavoured syrupy base Approved colour used | 200 500 | mg mg |
|
| Bacillus calusii spores suspension (2billion/5ml vial) | Each vial of oral suspension contains spores of Bacillus clausii Purified Water | 2 | Billion Spores | |
| Milk of Magnesia, Liquid Paraffin & Sodium Picosulphate Suspension | Each 5 ml contains Milk of Magnesia Liquid Paraffin Sodium Picosulphate In Flavoured Syrupy base Approved colour used | IP IP BP | 3.75 1.25 3.33 Q.S. | ml ml mg |
| Paracetamol , Chlorpheniramine Maleate & Phenylepherine Hcl Suspension | Each 5 ml Contains Paracetamol Chlorpheniramine Maleate Phenylepherine Hcl In a flavoured syrupy Base Approved color used | IP IP | 250 2 5 Q.S. | mg mg mg |
| Nitazoxanide Oral Suspension | Each 5 ml contains: Nitazoxanide In Flavoured syrupy base Approved colour used | 100 Q.S. | mg | |
| Ofloxacin , Metronidazole & Simethicone Suspension | Each 5 ml Contains Ofloxacin Metronidazole Benzoate Eq. to Metronidazole Simethicone In Flavoured Syrupy Base | IP IP IP | 50 120 10 Q.S. | mg mg mg |
| Sodium Valproate Oral Solution I.P | Each 5 ml Contains Sodium valproate In Flavoured Syrupy Base Approved colors used | IP | 200 Q.S. | mg |
| Ursodeoxycholic Acid Suspension 125 mg/5ml | Each 5 ml Contains Ursodeoxycholic Acid In Flavoured Syrupy Base Approved colors used | IP | 125 Q.S. | mg |
| Ursodeoxycholic Acid Suspension 250 mg/5ml | Each 5 ml Contains Ursodeoxycholic Acid In Flavoured Syrupy Base | IP | 250 Q.S. | mg |
| Ofloxacin & Racecadotril Suspension | Each 5 ml contains Ofloxacin Racecadotril In Flavoured syrupy base Approved colour used | IP IP | 50 15 Q.S. | mg mg |
| Paracetamol, Phenylephrine HCl, Chlorpheniramine, Sodium citrate & menthol Suspension | Each 5 ml contains Paracetamol Phenylephrine HCl Chlorpheniramine Sodium citrate Menthol In flavoured Syrupy base Approved colour used | IP IP IP IP IP | 125 5 0.5 60 1 Q.S. | mg mg mg mg mg |
| Paracetamol, Chlorpheniramine maleate,Phenylephrine HCl, Sodium citrate & menthol Suspension | Each 5 ml contains Paracetamol Chlorpheniramine Maleate Phenylephrine HCl Sodium Citrate Menthol In flavoured Syrupy base Approved colour used | IP IP IP IP IP | 250 2 5 60 1 Q.S. | mg mg mg mg mg |
| Paracetamol suspension IP | Each 5 ml contains Paracetamol flavoured syrupy base Approved Colour used Colour : approved colour used | IP | 250 Q.S. | mg |
| Paracetamol, Phenylephrine HCl, Chlorpheniramine maleate, Sodium citrate & menthol Suspension | Each 5 ml contains Paracetamol Phenylephrine HCl chlorpheniramine maleate Sodium citrate menthol In flavoured Syrupy base Approved colour used | IP IP IP IP IP | 250 5 2 60 1 Q.S. | mg mg mg mg mg |
| Deflazacort oral suspension | Each 5 ml contains Deflazacort flavoured syrupy base Each uncoated tablet contains | 6 | mg | |
| Ferrous Ascorbate & Folic acid suspension | Each 5 ml contains Ferrous Ascorbate Equivalent to elemental Iron Folic acid In flavored syrupy base Approved colour used | IP | 30 550 Q.S. | mg mg |
| Mefenamic Acid 50mg & Paracetamol 125 mg Suspension | Each 5 ml contains Mefenamic Acid Paracetamol Excipients Approved Colour Used | IP IP | 50 125 Q.S. | mg mg |
